YOKNEAM, Israel, Feb. 3, 2025
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global
provider of innovative medical technologies, today announced that
Yair Malca, Chief Financial Officer
will host investor meetings at the BTIG MedTech, Digital Health,
Life Sciences & Diagnostics Tools Conference in Snowbird, UT on Wednesday, February 12, 2025.
Interested investors are welcome to contact their BTIG
salesperson and schedule a meeting.
For more information about the event, visit InMode's investor
relations site here.
About InMode
InMode is a leading global provider of innovative medical
technologies. InMode develops, manufactures, and markets devices
harnessing novel radiofrequency ("RF") technology. InMode strives
to enable new emerging surgical procedures as well as improve
existing treatments. InMode has leveraged its medically accepted
minimally invasive RF technologies to offer a comprehensive line of
products across several categories for plastic surgery, gynecology,
dermatology, otolaryngology, and ophthalmology. For more
information about InMode and its wide array of medical
technologies, visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo -
https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-the-btig-medtech-digital-health-life-sciences--diagnostics-tools-conference-302365604.html
SOURCE InMode LTD
